Magnetic Delivery of Antigen‐Loaded Magnetic Liposomes for Active Lymph Node Targeting and Enhanced Anti‐Tumor Immunity
Advanced Healthcare Materials · 2023-12 · 12 (32)
DOI: 10.1002/adhm.202301232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 22.09.2023. Verfasst von Jingyi Sheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, 21…. Hauptthemen laut MEDLINE: Cancer Vaccines, Melanoma. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Key Research and Development Project, State Key Program of National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Therapeutic cancer vaccines offer the greatest advantage of enhancing antigen‐specific immunity against tumors, particularly for immunogenic tumors, such as melanoma. However, clinical responses remain unsatisfactory, primarily due to inadequate T cell priming and the development of acquired immune tolerance. A major obstacle lies in the inefficient uptake of antigen by peripheral dendritic cells (DCs) and their migration to lymph nodes for antigen presentation. In this context, the magnetic delivery of antigen‐loaded magnetic liposomes (Ag‐MLs) to actively target lymph node, is proposed. These magnetic responsive liposomes contain soluble mouse melanoma lysate and iron oxide nanoparticles in the core, along with the immunostimulatory adjuvant CpG‐1826 incorporated into the lipid bilayer. When applied through magnetic targeting in the mouse melanoma model, Ag‐MLs accumulate significantly in the target lymph nodes. This accumulation results in increased population of active DCs in lymph nodes and cytotoxic T lymphocytes (CTLs) within tumors, correlating with effective tumor growth inhibition. Overall, this study demonstrates the potential of magnetic targeting as an effective strategy for delivering cancer vaccines and activating the immune response, offering a novel platform for cancer immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, 210009, P. R. China.
- Department of Foodborne Disease and Food Safety Risk Surveillance, Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510440, P. R. China.
- School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing, 211166, P. R. China.
- Medical School, Nanjing University, Nanjing, 210093, P. R. China.
ORCID-Profile: Ning Gu
Förderung
- National Key Research and Development Project
- State Key Program of National Natural Science Foundation of China
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Sheng, J., Liu, Y., Ding, H., Wu, L., Liu, L., Si, G., Shen, Y., Yang, F., & Gu, N. (2023). Magnetic Delivery of Antigen‐Loaded Magnetic Liposomes for Active Lymph Node Targeting and Enhanced Anti‐Tumor Immunity. Advanced Healthcare Materials, 12(32). https://doi.org/10.1002/adhm.202301232
Vancouver
Sheng J, Liu Y, Ding H, Wu L, Liu L, Si G, et al. Magnetic Delivery of Antigen‐Loaded Magnetic Liposomes for Active Lymph Node Targeting and Enhanced Anti‐Tumor Immunity. Advanced Healthcare Materials. 2023;12(32). doi:10.1002/adhm.202301232
BibTeX
@article{Sheng2023,
author = {Sheng, Jingyi and Liu, Yang and Ding, He and Wu, Linyuan and Liu, Lan and Si, Guangxiang and Shen, Yan and Yang, Fang and Gu, Ning},
title = {Magnetic Delivery of Antigen‐Loaded Magnetic Liposomes for Active Lymph Node Targeting and Enhanced Anti‐Tumor Immunity},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {32},
doi = {10.1002/adhm.202301232}
}
EUVIMED